NSE filing, NSE: LALPATHLAB. Summary written from the filing by ALFA Finder's alert engine.
Dr. Lal Pathlabs Ltd: key numbers
- Share price
- ₹2,045.00
- Market cap
- ₹34,325 Cr
- Revenue (annual)
- ₹2,763 Cr
- Net profit (annual)
- ₹504.8 Cr
- P/E (TTM)
- 58.8×Sector 53.8×
- Promoter holding
- 52.93%-0.26% QoQ
- FII holding
- 18.73%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Dr. Lal Pathlabs Ltd
All →Dr. Lal Pathlabs Management Change
Dr. Lal Path Labs appointed Ms. Vasuta Agarwal as an additional Non-Executive Independent Director for three years from 4 November 2026. Her appointment is subject to member approval by postal ballot.
- Execution
- 36 months from 04-11-2026
Dr. Lal Pathlabs Capital Structure Change
Dr. Lal PathLabs will invest up to Rs 49.5 Crore in its wholly owned Dubai subsidiary, in tranches. Funds cover operations and further investment in Ghana's SHL.
- Value
- ₹49.50 Cr
- Execution
- Indicative completion by 31 March 2027, in tranches
Dr. Lal Pathlabs Dividend
Dr. Lal Path Labs approved a Rs 5 per share second interim dividend. Record date is November 11, 2026; payment by December 3, 2026.
Dr. Lal Pathlabs Investor Presentation: Key Takeaways
Q2 FY27 revenue Rs 874 Cr (+19.6%), EBITDA Rs 280 Cr (32.1% margin), PAT Rs 194 Cr (+27.5%). Strategy: AI diagnostics, rural GraminFit, M&A.
Dr. Lal Pathlabs Q2 FY27 Results: Net Profit ₹193.9 Cr, Up 27.4% YoY
Dr. Lal Pathlabs Ltd reported revenue from operations of ₹873.9 Cr (+19.6% YoY) and net profit of ₹193.9 Cr (+27.4% YoY) for Q2 FY27.
- Key figure
- Net profit ₹193.9 Cr · +27.4% YoY
Dr. Lal Pathlabs Board Meeting Date
Dr. Lal PathLabs updated its 4 November 2026 board meeting notice to add a possible second interim dividend. The meeting will also approve unaudited quarterly results.
Other management change announcements
All →Krishna Institute of Medical Sciences Management Change
KIMS re-appointed Dr. Abhinay Bollineni as Director & CEO, Dr. Bhaskara Rao Bollineni as CMD, and Ms. Dandamudi Anitha as Whole-time Director. Terms start in 2027.
- Execution
- 5 years
Krowniq Management Change
Krowniq Limited appointed Mr. Mahesh Sharma as Company Secretary and Compliance Officer, effective 04-11-2026, following a board meeting on the same day. The filing is a Key Managerial Personnel change disclosure.
One Global Service Provider Management Change
One Global Service Provider appointed Padmakar Pandit as Non-Executive Independent Director for 60 months. Sanjay Upadhyay was re-appointed Executive Director, effective April 22, 2027.
Whirlpool of India Management Change
Whirlpool of India disclosed the resignations of Head-Accounting Prafulla Kandpal and Head-Taxation Vijay Waghmore. Their relieving dates are 30 October and 13 November 2026.
PDS Management Change
PDS Limited disclosed the resignation of Non-Executive Independent Director Bangalore Gangaiah Srinivas, effective November 4, 2026. The resignation cites pre-occupation and personal commitments, with no other material reason.
Arvee Laboratories (India) Management Change
Arvee Laboratories appointed Shalin Chokshi as Executive Director and Duttsagar Chavda as Company Secretary, both effective 3 November 2026. Non-executive director Saurin Gandhi resigned from the Board effective the same date.